Zijlstra, J.M.; Follows, G.; Casasnovas, R.-O.; Vermaat, J.S.P.; Kalakonda, N.; Choquet, S.; Hill, B.; Thieblemont, C.; Cavallo, F.; Cruz, F.D.l.;
et al. The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers 2022, 14, 791.
https://doi.org/10.3390/cancers14030791
AMA Style
Zijlstra JM, Follows G, Casasnovas R-O, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz FDl,
et al. The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers. 2022; 14(3):791.
https://doi.org/10.3390/cancers14030791
Chicago/Turabian Style
Zijlstra, Josée M., George Follows, Rene-Olivier Casasnovas, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz,
and et al. 2022. "The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study" Cancers 14, no. 3: 791.
https://doi.org/10.3390/cancers14030791
APA Style
Zijlstra, J. M., Follows, G., Casasnovas, R.-O., Vermaat, J. S. P., Kalakonda, N., Choquet, S., Hill, B., Thieblemont, C., Cavallo, F., Cruz, F. D. l., Kuruvilla, J., Hamad, N., Jaeger, U., Caimi, P., Gurion, R., Warzocha, K., Bakhshi, S., Sancho, J.-M., Schuster, M.,
... Maerevoet, M.
(2022). The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers, 14(3), 791.
https://doi.org/10.3390/cancers14030791
